PMID: 6988473Apr 1, 1980Paper

Current concepts in the classification of connective tissue diseases. Overlap syndromes and mixed connective tissue disease (MCTD)

Journal of the American Academy of Dermatology
G C Sharp, P C Anderson

Abstract

New principles are discussed for the classification of the diffuse collagen diseases, particularly the mixed connective tissue disease (MCTD), with clinical and historical explanation. Emphasis in classification has shifted from a concern with tissue pathology to serologic anomalies, which may involve eleven different antigens, many from human cell nuclei. New serologic tests, such as the ribonucleoprotein (RNP) antibody test, may be superior to the well-known fluorescent antinuclear antibody (ANA) studies for diagnosis and follow-up of diffuse collagen diseases. Functional clinical studies, such as esophageal motility, gas exchange in the lung, and major joint mobility, which may appear early in MCTD, are more important to diagnosis than anatomic studies of late-developing lesions.

References

Jun 1, 1977·The Journal of Pediatrics·B H SingsenE M Tan
Sep 1, 1977·Arthritis and Rheumatism·E M TanE V Barnett
Sep 1, 1978·Arthritis and Rheumatism·D A Norman, R M Fleischmann
Jan 1, 1977·The Journal of Clinical Investigation·J F WolfeG C Sharp
May 1, 1977·Arthritis and Rheumatism·R OxenhandlerE Adelstein
Jun 1, 1978·Arthritis and Rheumatism·J T Halla, J G Hardin
Feb 1, 1975·British Medical Journal·D KitchinerG R Hughes
Oct 1, 1975·Annals of Internal Medicine·D D NotmanE M Tan
Jul 1, 1975·Annals of Internal Medicine·P M LevitinV J Giuliano
Jan 1, 1967·Acta Rheumatologica Scandinavica·F Lenoch, O Vojtísek
Jun 30, 1965·Annals of the New York Academy of Sciences·H R Holman
Jun 1, 1956·Southern Medical Journal·S W ROSS, E K CLARDY
Sep 1, 1961·Archives of Dermatology·D L TUFFANELLI, R K WINKELMANN
Mar 1, 1955·Journal of Chronic Diseases·J R HASERICK
Oct 4, 1952·Journal of the American Medical Association·J E MOORE, C F MOHR

❮ Previous
Next ❯

Citations

Oct 19, 2000·Arthritis and Rheumatism·A BrunsF Hiepe
Jan 1, 1984·Virchows Archiv. A, Pathological Anatomy and Histopathology·N UedaH Fukuzaki
Dec 1, 1984·Clinical Rheumatology·J CalderonJ Gomez-Reyno
Jan 26, 1999·Clinics in Chest Medicine·U B Prakash
Oct 30, 2013·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·D C FerreiraM A B Cavalcante
Apr 1, 1984·The Journal of Dermatology·T ShishibaS Hasegawa
Jul 6, 2000·Baillière's Best Practice & Research. Clinical Rheumatology·P J Maddison
Oct 1, 2011·Seminars in Arthritis and Rheumatism·Susanna CappelliMarco Matucci Cerinic
Oct 1, 1992·Clinics in Dermatology·S JablonskaE H Beutner
Sep 1, 1982·Clinical and Experimental Dermatology·E NunziA Rebora
Jan 1, 1981·Journal of the American Academy of Dermatology·T K Burnham
Oct 1, 1984·Oral Surgery, Oral Medicine, and Oral Pathology·A M Rich, P C Reade
Aug 1, 1982·The Australasian Journal of Dermatology·H O Perry
Apr 1, 1997·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·H B WeissJ H Coben
Feb 1, 1984·American Journal of Medical Genetics·D O SillenceD L Rimoin
Sep 1, 1989·British Journal for the History of Science·N Roll-Hansen
Jun 1, 1981·The British Journal of Dermatology·C Black
Oct 1, 1990·The British Journal of Dermatology·M BłaszczykV Kumar
Dec 1, 1983·The Journal of Dermatology·Y KobayashiS Sano
Jun 1, 1985·Journal of Cutaneous Pathology·L E Golitz
Aug 1, 1986·Seminars in Arthritis and Rheumatism·V K Rocco, E R Hurd

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.